Form D · Private Equity Fund

OrbiMed Private Investments VIII, LP

New York, NY · CIK 0001815328

Offering snapshot reported Aug 27, 2020 · SEC filing

Reported sold
Yet to sell
Offering amount: $1.4B
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 27, 2020InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-374300

Source: Form D, filed Aug 27, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ORBIMED PRIVATE INVESTMENTS VIII, LP

Investment adviser: ORBIMED ADVISORS LLC

Gross asset value
$1.68B
Beneficial owners
186
ADV minimum commitment
$10M

Reported in Form ADV on Aug 18, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SS&C TECHNOLOGIES, INC. NEW YORK, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LLP NEW YORK, New York, United States
Custodian JPMORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No
Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG LLP
PCAOB 185

Filing source

Form ADV 2126532 · Aug 18, 2026 · Schedule D 7.B.(1), fund 805-2462443195

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David P. Bonita Executive
Sven H. Borho Executive
Carl L. Gordon Executive
Geoffrey C. Hsu Executive
W. Carter Neild Executive
N/A Orbi Med Advisors Llc Executive
N/A Orbi Med Capital Gp Viii Llc Executive
Jonathan T. Silverstein Executive
C. Scotland Stevens Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
601 Lexington Avenue 54 Th Floor
New York, NY, 10022